$183MSeries C, 22 October 2025
Funds a registrational Phase 2/3 study of ELA026 in sHLH and expansion into hematologic cancers.
- Amount
- $183M
- Stage
- Series C
- Announced
- 22 October 2025
- Lead
- Nextech Invest
- Other investors
- EQT Life Sciences, Sanofi, HBM Healthcare Investments, Mubadala Capital
- Use of funds
- Funds a registrational Phase 2/3 study of ELA026 in sHLH and expansion into hematologic cancers.
- Checked
- Announced by the company
- Sources
- Electra Therapeutics raises $183M Series C (date approx) inderes.se
Electra Therapeutics raises $183M Series C (date approx) news.crunchbase.com